Dioscorea spongiosa

Dioscorea spongiosa · Accepted scientific name

Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆

Dioscorea spongiosa is a specialized plant species known for its significant medicinal potential. The primary source of its bioactive compounds is the plant's rhizome. Within this part, researchers have identified key chemicals such as Dioscin, Hypoglaucin G, Methylprotodioscin, and Spongiosides A. These specific constituents are of great interest due to their unique pharmacological profiles. Most notably, the plant exhibits promising antiosteoporotic activities that make it a subject of valuable scientific study.

Quick facts
Synonyms
Not available
Common names
Not available
Family
Dioscoreaceae
Distribution
Asia-Tropical
Plant Parts
Rhizome

Classification

Common Names

Dioscorea spongiosa is a distinctive plant species that is widely recognized by various regional names. In many contexts, it is referred to by its common name, mian bei xie. This same identity is also expressed through its traditional Chinese name, 綿萆薢. Understanding these linguistic variations is essential for anyone studying the plant's cultural or medicinal significance. Such nomenclature helps bridge the gap between scientific classification and local herbal traditions.

Sources: Catalogue of Life (COL)

Taxonomy

Dioscorea spongiosa is a distinctive biological entity that belongs to the vast kingdom Plantae. Within this expansive realm, the plant is classified under the class Equisetopsida. It further resides in the order Dioscoreales, which helps define its evolutionary lineage. The species is a member of the Dioscoreaceae family, showcasing its specific botanical traits. Ultimately, this plant is categorized under the genus Dioscorea, placing it among its close relatives.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Dioscoreales
Family Dioscoreaceae
Genus Dioscorea

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Dioscorea spongiosa is a plant species primarily found within the temperate regions of Asia. Its geographical footprint is notably concentrated within the vast landscapes of China. Specifically, the species thrives throughout the South-Central parts of the country. It also maintains a significant presence across the Southeast regions of China. This localized distribution highlights the specific environmental niches that support its growth.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Dioscorea spongiosa relies on an obligatory climbing habit to reach the sunlight necessary for its survival.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Dioscorea spongiosa exhibits significant potential in the treatment of bone density loss due to its demonstrated antiosteoporotic activity. Research into the plant's rhizomes has led to the isolation of several unique steroidal glycosides, including new pregnane and cholestane derivatives. Specifically, compounds such as spongioside A and hypoglaucin G have proven to be highly effective in laboratory settings. These substances show a potent ability to inhibit bone resorption triggered by parathyroid hormone within bone organ culture systems. Such findings highlight the importance of this species in the ongoing search for natural therapeutic agents to combat osteoporosis.

Compounds

Dioscorea spongiosa is a plant species known for containing a diverse array of bioactive steroidal glycosides within its rhizomes. Among these significant chemical constituents are dioscin and methylprotodioscin, which have been studied for their potential medicinal effects. The plant also yields unique compounds such as hypoglaucin G and the cholestane glycoside spongioside A. Research further identifies the presence of spongiosides A, highlighting the complex chemical profile of this species. These various relationships underscore the botanical importance of Dioscorea spongiosa in pharmacological studies.

Conditions

Dioscorea spongiosa exhibits significant antiosteoporotic activity through the properties of its rhizome water extracts. Research indicates that this plant can effectively treat bone resorption induced by parathyroid hormone. Specifically, various isolated steroidal glycosides from the plant demonstrate a potent inhibitory effect against such bone resorption in organ culture systems. Compounds like spongioside A and hypoglaucin G are identified as key components in this medicinal process. Consequently, the plant serves as a valuable source of bioactive glycosides for addressing bone density issues.

Preparations

Parts used

Dioscorea spongiosa contains bioactive steroidal glycosides primarily located within its rhizome. Scientific analysis of these rhizomes involves using water extracts to isolate various unique chemical compounds. Researchers have successfully identified several new pregnane and cholestane glycosides, such as spongipregnolosides A-D and spongiosides A and B, from this specific plant part. These isolated substances have demonstrated significant potential in medicinal studies, particularly regarding bone health. Specifically, certain compounds found in the rhizome show potent inhibition against bone resorption in controlled organ culture systems.